Patient recruitment is where most delays in clinical trials occur, incurring huge costs and the loss of potential sales.  In fact, according to Applied Clinical Trials, 86% of trials experience delays, and CenterWatch reports that 81% of these delays are one to six months in length, while another 5% are even longer.

Take a look at our detailed infographic, filled with eye-opening statistics, to learn more about some of the struggles and solutions around patient recruitment:

Recruitment delays can compound costs by delaying the time to product approval, often decreasing the period of exclusivity post-launch.  Further, slow enrollment can lead to waning patient and site staff interest, increased staff turnover, and possible abandonment of a promising treatment.

Increasingly, sponsors and CROs start looking into patient recruitment at the onset of the trial launch (reflective of a patient-centric model), rather than waiting for investigators to become involved.  These parallel efforts of recruitment and site start-up can speed the enrollment process, improving the overall trial timeline.

Choosing a site with a large patient population that aligns with the study protocol will also significantly facilitate patient recruitment. Multiple methods are used today to recruit patients, combining traditional tactics with an escalating adoption of newer media forms. As advances in technology soar, it will continue to enable smarter, more targeted recruitment of patients and investigators, utilizing data to identify investigators with the right skills and access to study patient populations.

If you’re interested in more information on trends in clinical trial site selection and patient recruitment, please click here to watch the recorded webcast and here to download our related eBook.